The United Kingdom has pledged emergency health funding for South Africa, compensating for the sudden withdrawal of American financial support for HIV treatment programmes. The move, announced by the Foreign Office on Thursday, ensures the continuity of antiretroviral therapy for over 200,000 patients who faced an immediate disruption in care.
The decision follows the Trump administration’s abrupt cancellation of grants to the South African National AIDS Council, part of a broader review of foreign aid allocations. The US had provided approximately $400 million annually through the President’s Emergency Plan for AIDS Relief, representing nearly 60 per cent of South Africa’s HIV treatment budget. The termination of these funds, effective immediately, threatened to reverse decades of progress in combating the epidemic.
British officials described the emergency package as a “bridge measure” designed to stabilise the treatment pipeline until a longer-term solution can be negotiated. The exact value of the UK pledge has not been disclosed, but sources within the Department for International Development indicated it would cover essential drug procurement for the next six months.
The African National Congress government welcomed the intervention but issued a carefully worded statement expressing regret over the unilateral American decision. Health Minister Aaron Motsoaledi warned that the funding gap could undermine gains in reducing HIV transmission rates, which have fallen by nearly 40 per cent since 2010.
International health organisations have criticised the US move, describing it as a blow to global health security. The World Health Organization noted that South Africa accounts for 20 per cent of the world’s HIV cases and nearly a third of new infections in sub-Saharan Africa.
For the UK, the pledge reinforces its commitment to multilateral health initiatives at a time when American leadership in this arena appears to be waning. However, the sustainability of such ad hoc arrangements remains uncertain. British diplomats are now pressing Washington to reverse its decision, arguing that the funding gap could lead to a resurgence of the virus across the region.
The HIV crisis in South Africa remains one of the most pressing public health challenges on the continent. With the US stepping back, the UK’s role has shifted from a supporting actor to a central guarantor of treatment continuity. Whether this marks a permanent realignment of international health aid or a temporary measure will depend on the outcome of ongoing diplomatic efforts.